Skip to content

Effect of Dadimsara and Bhunimba vati in vomiting during pregnancy.

A comparative study between Dadimsara vati and Bhunimba vati in Garbhini chhardi - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065222
Enrollment
60
Registered
2024-04-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O219- Vomiting of pregnancy, unspecified

Interventions

None listed

Sponsors

Department of Prasuti Tantra Faculty of Ayurveda IMSBHU
Lead Sponsor
Dr Akhilendra Mohan Mishra
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients willing to participate in the research work after giving well informed written consent in predesigned proforma 2 pregnant women primi gravida or multigravida between the age group of 20-35 years coming for antenatal checkup with along with complaints of vomiting and nausea. 3 vomiting should be of mild(NVP=6)to moderate degree(NVP 7- 12).

Exclusion criteria

Exclusion criteria: 1. Age group 20 years and 35 years. 2 Unconscious patient and psychiatric illness. 3 History of moderate to severe episodes of vomiting during previous pregnancy. 4 Patient having moderate to severe dehydration.5 Women of molar pregnancy. 5 Cases with vomiting due to causes other than pregnancy like migraine, gastroenteritis, TORCH infection or any other infection, acid reflux, Ovarian cyst, tumor, peptic ulcer, appendicitis and cholecystitis etc. 6 Suffering from any chronic illness eg. Gastrointestinal diseases, Severe anaemia, Jaundice, Diabetes, Blood Coagulopathy, Skin diseases (psoriasis, eczema, seborrheic dermatitis, necrotizing fasciitis), Tuberculosis, Bronchial Asthma, Malnourished, Very obese, Hypothyroidism, Hypertension, Liver diseases, Heart diseases, Renal diseases etc. 7 Malignancy or any benign tumor of any organ.8 Women of early pregnancy with genital tract diseases like gonorrhoea, HIV and STDs. 9 Any allergy to any drug or trial drug.

Design outcomes

Primary

MeasureTime frame
significant Improvement in Nausea and Vomiting in pregnant women is seen with Dadimsara vati and Bhunimba vatiTimepoint: o, 15th, 30th, 45th, 60th

Secondary

MeasureTime frame
SIGNIFICANT IMPROVEMENT IN SYMPTOMSTimepoint: 10

Countries

India

Contacts

Public ContactDr Akhilendra Mohan Mishra

Institute of Medical Sciences Banaras Hindu University

drsunitasuman@gmail.com7607165096

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026